| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/30/2004 | WO2004082718A1 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/30/2004 | WO2004082679A1 Release control compositions |
| 09/30/2004 | WO2004082631A2 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2 |
| 09/30/2004 | WO2004082579A2 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004064785A9 Cancer therapy sensitizer |
| 09/30/2004 | WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 09/30/2004 | WO2004029092A3 Antibody for adcc and inducing cytokine production |
| 09/30/2004 | WO2004028564A3 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 09/30/2004 | WO2004022059A3 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 09/30/2004 | WO2003101383A3 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003082200A3 Potent oncolytic herpes simplex virus for cancer therapy |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003048328A9 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/30/2004 | WO2003031930A3 A phosphatase associated with metastasis |
| 09/30/2004 | WO2003026645A8 Tetrapeptide derivative crystals |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192908 Human and veterinary medicine; drugs, cosmetics ; prevention therapy dyslipidemia; cardiovascular disorders; antidiabetic agents; obesity; hypotensive agents; antiaging agents; anticancer agents |
| 09/30/2004 | US20040192900 Calicheamicin derivative-carrier conjugates |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192776 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
| 09/30/2004 | US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192726 Farnesyl protein transferase inhibitors for treating breast cancer |
| 09/30/2004 | US20040192723 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 09/30/2004 | US20040192717 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 09/30/2004 | US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents |
| 09/30/2004 | US20040192689 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192686 Potentiators of the cytotoxicity of anticancer drugs; antitumor agents |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192679 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040192665 Mesoporphyrin IX covalently linked to doxorubicin; anticarcinogenic, antiproliferative, and antitumor agents; side effect reduction |
| 09/30/2004 | US20040192654 use of nucleoside analogues as an effective treatment for acute or chronic myelogenous leukemia; (-)- beta -L-Dioxolane-Cytidine ( beta -L-oddC); (-)- beta -Dioxolane-5-fluoro-Cytidine (5-FddC) |
| 09/30/2004 | US20040192652 Pharmaceutical combinations and methods for the treatment of leukemia |
| 09/30/2004 | US20040192651 substituted cyclic phosphate diesters of 1-aryl-1,3-propane diols, that have the trans-stereochemistry and their use to synthesize phosphate prodrugs that have the cis-configuration; use of these trans-phosphorylating reagents for the stereoselective synthesis of cis-phosphate prodrugs |
| 09/30/2004 | US20040192637 HPMPC [(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine]; kits; cytotoxicity; inhibition against viral and/or cellular polymerases; treatment of non virus-associated cancers |
| 09/30/2004 | US20040192628 gene expression inhibition of the kinase to prevent neovascularization, treat cancer |
| 09/30/2004 | US20040192623 Aloe-emodin derivatives and their use in the treatment of neoplasias |
| 09/30/2004 | US20040192621 Anti-tumor agent |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192585 Administering to a patient an amount of IRM(immune respose modifier) compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered |
| 09/30/2004 | US20040192579 Administration of the mammal a formulation containing a matrine component and dictamnine in amount effective to deliver daily amount of at least 15 mu mole of a matrine component and at least 0.15 mu mole of dictamnine/kg of body weight to treat cancer |
| 09/30/2004 | US20040191843 Cytotoxic mixture comprising polypeptides for treatment and prevention of cell proliferfative disorders |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191342 Such as beta-caryophyllene extracted from plant oil |
| 09/30/2004 | US20040191310 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 09/30/2004 | US20040191304 Vaccine adjuvant properties of lipsomes formed at elevated temperatures from the polar chloroform extractable lipids from mycobacterium bovis bacillus calmette-guerin |
| 09/30/2004 | US20040191303 Inhibiting adhesion of cells to activated vascular endothelium from bloodstream; proteins and glycoproteins isolated from human or animal amniotic fluid, serum or urine |
| 09/30/2004 | US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | US20040191254 Administering compound to decrease epidermal growth factor activity; anticarcinogenic agents for thyroid cancer mediated by mutations in RET gene |
| 09/30/2004 | US20040191242 Method for producing a vaccine |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |
| 09/30/2004 | US20040191230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
| 09/30/2004 | US20040191223 Combinatorial methods for inducing cancer cell death |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191218 Pharmaceutical compositions and methods for treating cancer |
| 09/30/2004 | US20040191214 Nucleoside vaccine adjuvants |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | DE10314780A1 Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden Protein-binding derivatives of platinum complexes with cyclobutane-1,1-dicarboxylate |
| 09/30/2004 | DE10311248A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 09/30/2004 | DE10202468A1 Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung Pteridine derivatives, processes for their preparation and their use |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2519860A1 Short interfering rna (sirna) analogues |
| 09/30/2004 | CA2519457A1 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 09/30/2004 | CA2519289A1 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | CA2519211A1 Release control compositions |
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | CA2517125A1 Methods for preparation and use of 1.alpha.,24(s)-dihydroxyvitamin d2 |
| 09/29/2004 | EP1462526A1 Novel tetronic acid derivative |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462456A1 Tumor antigens |
| 09/29/2004 | EP1462449A1 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 09/29/2004 | EP1462132A1 Drug releasing elastic band and method |
| 09/29/2004 | EP1462125A2 Adhesive antineoplastic compositions |
| 09/29/2004 | EP1462113A1 CELL GROWTH INHIBITOR CONTAINING ANTI-PepT ANTIBODY |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461457A2 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461449A2 System for monitoring bacterial tumor treatment |
| 09/29/2004 | EP1461448A2 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |